# Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

> **NCT05234177** · — · RECRUITING · sponsor: **Tempus AI** · enrollment: 300 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT05234177
- **Lead sponsor:** Tempus AI
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-21
- **Primary completion:** 2027-02
- **Final completion:** 2029-02
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05234177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05234177, "Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05234177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*